Staphylococcus aureus. When octreotide therapy was initiated, a toxic shock-like syndrome developed that was associated with fever, multisystem organ damage, and ultimately, desquamation of the palms and soles. The isolate was methicillin susceptible and produced enterotoxins B and C. This is, to our knowledge, the first reported case of toxic shock syndrome to develop secondary to staphylococcal enterocolitis in an adult.
His HIV serostatus was unknown. Multiple stool evaluations for enteric bacterial pathogens, parasites, and Clostridium difficile toxins A and B had negative results. The patient responded to rehydration and was discharged, but he was readmitted 1 week later because of continued diarrhea and recurrent azotemia (blood urea nitrogen level, 83 mg/dL; serum creatinine level, 7.1 mg/dL). Stool evaluations again had negative results. Colonoscopy was performed, revealing few cytomegalovirus inclusions but no inflammation. Treatment with oral valganciclovir (450 mg twice per day) was initiated, and the patient was discharged. During the second hospital visit, the patient was found to be HIV seropositive, with a CD4 + lymphocyte count of 117 cells/mm 3 and a plasma HIV RNA level of 15,000 copies/mL. Trimethoprim-sulfamethoxazole therapy was administered for Pneumocystis pneumonia prophylaxis, but treatment was switched to atovaquone after 3 days because the patient developed a rash.
The patient's diarrhea worsened, despite anti-cytomegalovirus infection therapy, and he was readmitted to the hospital 2 weeks later. He was hypotensive on physical examination. A mild, diffuse, erythematous, maculopapular eruption was noted on the patient's trunk and back that was attributed to the prior exposure to trimethoprim-sulfamethoxazole. Severe azotemia with acidosis and an elevated anion gap, progressive anemia, thrombocytosis, leukopenia, neutropenia, elevations of liver function, and a further decrease in CD4 + lymphocytes to 50 cells/mm 3 were found. Treatment with intravenous fluids and abacavir-lamivudine plus efavirenz was initiated.
Upper gastrointestinal endoscopy demonstrated grossly normal mucosa; examination of tissue biopsy samples also had normal findings. Colonoscopy revealed grossly abnormal ileal mucosa with villus flattening, and there was marked colonic edema. Biopsies of tissue samples obtained from the ileum and colon demonstrated superficial acute inflammation, mild chronic inflammation in the lamina propria, and evidence of epithelial cell injury and focal architectural disarray. Many cocci adherent to the superficial epithelium were observed under high-power magnification. Brown-Hopps stain confirmed the identification of the organisms as gram-positive cocci (figure 1A), and electron microscopy revealed clusters of organisms in close apposition to injured epithelial cells (figure 1B). Rare cytomegalovirus inclusions, but no acid-fast or protozoal organisms, were observed. The same day, stool culture findings reported moderate S. aureus that was susceptible to methicillin and most other antistaphylococcal antibiotics but was resistant to penicillin. The patient required ∼9 L/day of intravenous fluids, plus 12 L/day administered orally, to maintain hydration status. Loperamide and tincture of opium were added, but copious diarrhea persisted and severe azotemia recurred. Pharmacologic control of diarrhea was sought using octreotide in ascending doses to 250 mg subcutaneously every 8 h, after which the volume of diarrhea decreased substantially.
The patient then became febrile (temperature, 41ЊC) and developed a left brachial vein thrombosis. Despite administration of anticoagulation therapy with low molecular weight heparin, a second percutaneously inserted central catheter line later became occluded with a right brachial vein thrombosis. He also developed marked, nonpitting edema of the lower half of his body. The previously noted rash progressed, ultimately causing marked desquamation of the palms and soles, which is typical for TSS. Liver function levels worsened, with prominent hypoalbuminemia (1.8 g/dL) and marked elevations of levels of alkaline phosphatase (894 U/L; normal level, !125 U/L) and g-glutamyl transpepsidase (895 U/L; normal level, !50 U/L).
Treatment with intravenous vancomycin and cefepime was initiated, and octreotide was discontinued. The patient's condition improved rapidly, and his symptoms resolved completely over the next week. Multiple cultures of blood and urine samples taken at the time of the fever spike were without growth. Colonoscopy repeated 3 weeks after the completion of antibiotic therapy showed resolution of disease.
On the basis of the patient's clinical course and laboratory findings, the diagnosis of staphylococcal enterocolitis with TSS was made. Review of the colonoscopic biopsy specimens obtained during the previous hospital admission showed adherent cocci that had not been identified initially. The S. aureus isolate obtained from the stool sample culture was referred for toxin analysis and was found to produce both enterotoxins B and C, but not the TSS toxin-1 (TSST-1) [4] .
Discussion. TSS is characterized by fever, hypotension, rash, and variable multiorgan damage in association with infection by either S. aureus or Staphylococcus pyogenes [5] . In staphylococcal TSS, the causative organism often localizes on a mucosal surface. The syndrome is caused by a family of exotoxins (referred to as superantigens) that cause massive cytokine release from CD4 + lymphocytes and macrophages. Although toxin assays are typically performed on bacterial isolates, it is possible to perform assays on stool specimens themselves [3] .
Impaired, antigen-specific humoral immunity has been described in HIV-1 infection [6] and may be a predisposing factor in the development of TSS. Many S. aureus carriers have neutralizing antibodies that are specific for the superantigens in their colonizing strains [7] . Neutralizing antibodies to staphylococcal toxins were absent in the majority of cases of TSS in one series, and their absence correlated with the development of TSS in another [8, 9] . The lack of neutralizing antibodies may be a direct result of suppression of humoral immunity by the TSST-1 toxin. [10] .
This presentation fits the case definition for TSS [5] , although fecal losses contributed to volume depletion and azotemia in this case. Histologic and ultramicroscopic studies demonstrated gram-positive cocci in apposition to damaged epithelium (figure 1) . S. aureus was isolated from a stool specimen and expressed enterotoxins B and C, although not TSST-1. A lack of TSST-1 production is seen in approximately one-half of nonmenstruation-related cases of TSS [11] . We searched the PubMed database using the terms "enterocolitis" plus "staphylococcus," and "enterocolitis" plus "aureus," and we reviewed pertinent references describing staphylococcal enterocolitis. Although TSS secondary to staphylococcal enteritis has previously been reported in an infant [12] , this is the first adult case, to our knowledge.
Staphylococcal enterocolitis has had a complicated history.
Reports of the first cases of hospital-associated staphylococcal enteritis were published in 1942, and the first case of antibioticassociated staphylococcal enteritis was published in 1948 [13] . Many reports followed in the ensuing 2 decades, after which this entity virtually disappeared from the literature for more than a decade, before reemerging [2, 3] . As suggested by Rhee et al. [14] , this might be explained in part by changes in antibiotic use patterns. Early antibiotics inhibited neither S. aureus nor Clostridium difficile, allowing either species to overgrow, whereas clindamycin, used during the 1970s and early 1980s, inhibited S. aureus but not C. difficile. The more recent increased use of metronidazole, which has activity against C. difficile but not against S. aureus, may be associated with reemergence of this organism. Previous use of vancomycin for antibiotic-associated colitis, generally presumed to be due to C. difficile toxins, also may have masked disease caused by S. aureus.
Observations in this case and from older clinical descriptions suggest that staphylococcal enterocolitis and C. difficile colitis might be differentiated on clinical grounds. The diarrheal syndrome in patients with C. difficile colitis is typical for patients with colitis-that is, frequent, small-volume bowel movements, but infrequent dehydration. In contrast, staphylococcal enteritis affects both the small and large intestines and fluid losses may be great, as suggested by Bartlett [13] . A 1953 editorial in the New England Journal of Medicine on the topic of antibiotics and staphylococcal enteritis [15] specifically mentioned that the diarrheal syndrome often resembled cholera. In our case, the ileum was severely affected, resulting in copious diarrhea and necessitating fluid replacement with 110 L of fluid per day by combined oral and parenteral routes.
To our knowledge, no studies have specifically compared the histopathology of S. aureus-and C. difficile-related colitis. C. difficile is well known to produce a pseudomembraneous colitis, although not all cases demonstrate pseudomembranes, with ischemic features that are most prominent histologically. In contrast, the colonic and ileal mucosae in this case and in some published reports were edematous diffusely, without pseudomembranes, ulcerations, or other mucosal lesions.
This case also illustrates the potential dangers of administration of antidiarrheal therapy in cases of infectious enteritis. Although guidelines usually proscribe antidiarrheal agents for patients with bloody diarrhea or proven infections with Shiga toxin-producing Escherichia coli, our patient had nonbloody diarrhea, and antidiarrheal use was prompted by volume of hydration required. Octreotide, an octapeptide of somatostatin well known for its ability to inhibit intestinal and pancreatic fluid secretion, is effective in the treatment of some patients with AIDS who have severe diarrhea [16] . However, its use appears in this case to have promoted full expression of TSS, because clinical progression was temporally related to treatment-associated reduction in stool volume. The possible mechanism is a decrease in fecal clearance of luminally produced toxin, allowing for greater transmembrane uptake.
In summary, this case demonstrates that TSS may develop as a consequence of staphylococcal enterocolitis. As such, these observations suggest that the gastrointestinal tract may be an important reservoir of S. aureus.
